Gene Editing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509241342

Publication Date:

September 24, 2024

Pages:

122

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
The global market for Gene Editing was estimated to be worth US$ 3093.1 million in 2023 and is forecast to a readjusted size of US$ 5441.3 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Editing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Gene Editing by region & country, by Type, and by Application.
The Gene Editing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Editing.
Market Segmentation
By Company
Thermo Fisher Scientific
Merck
Horizo鈥嬧€媙 Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
Segment by Type:
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
Segment by Application
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gene Editing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Gene Editing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Gene Editing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Gene Editing Product Introduction
1.2 Global Gene Editing Market Size Forecast
1.3 Gene Editing Market Trends & Drivers
1.3.1 Gene Editing Industry Trends
1.3.2 Gene Editing Market Drivers & Opportunity
1.3.3 Gene Editing Market Challenges
1.3.4 Gene Editing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gene Editing Players Revenue Ranking (2023)
2.2 Global Gene Editing Revenue by Company (2019-2024)
2.3 Key Companies Gene Editing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Gene Editing Product Offered
2.5 Key Companies Time to Begin Mass Production of Gene Editing
2.6 Gene Editing Market Competitive Analysis
2.6.1 Gene Editing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Gene Editing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Zinc finger nucleases (ZFNs)
3.1.2 Transcription Activator-Like Effector-based Nucleases (TALENs)
3.1.3 CRISPR-Cas system
3.2 Global Gene Editing Sales Value by Type
3.2.1 Global Gene Editing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Gene Editing Sales Value, by Type (2019-2030)
3.2.3 Global Gene Editing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotechnology & Pharmaceutical Companies
4.1.2 Academic & Government Research Institutes
4.1.3 Contract Research Organizations
4.2 Global Gene Editing Sales Value by Application
4.2.1 Global Gene Editing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Gene Editing Sales Value, by Application (2019-2030)
4.2.3 Global Gene Editing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Gene Editing Sales Value by Region
5.1.1 Global Gene Editing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Gene Editing Sales Value by Region (2019-2024)
5.1.3 Global Gene Editing Sales Value by Region (2025-2030)
5.1.4 Global Gene Editing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Gene Editing Sales Value, 2019-2030
5.2.2 North America Gene Editing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Gene Editing Sales Value, 2019-2030
5.3.2 Europe Gene Editing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Gene Editing Sales Value, 2019-2030
5.4.2 Asia Pacific Gene Editing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Gene Editing Sales Value, 2019-2030
5.5.2 South America Gene Editing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Gene Editing Sales Value, 2019-2030
5.6.2 Middle East & Africa Gene Editing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gene Editing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Gene Editing Sales Value
6.3 United States
6.3.1 United States Gene Editing Sales Value, 2019-2030
6.3.2 United States Gene Editing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Gene Editing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Editing Sales Value, 2019-2030
6.4.2 Europe Gene Editing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Gene Editing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Gene Editing Sales Value, 2019-2030
6.5.2 China Gene Editing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Gene Editing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Gene Editing Sales Value, 2019-2030
6.6.2 Japan Gene Editing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Gene Editing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Gene Editing Sales Value, 2019-2030
6.7.2 South Korea Gene Editing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Gene Editing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Gene Editing Sales Value, 2019-2030
6.8.2 Southeast Asia Gene Editing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Gene Editing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Gene Editing Sales Value, 2019-2030
6.9.2 India Gene Editing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Gene Editing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Gene Editing Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Gene Editing Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Merck
7.2.1 Merck Profile
7.2.2 Merck Main Business
7.2.3 Merck Gene Editing Products, Services and Solutions
7.2.4 Merck Gene Editing Revenue (US$ Million) & (2019-2024)
7.2.5 Merck Recent Developments
7.3 Horizo鈥嬧€媙 Discovery
7.3.1 Horizo鈥嬧€媙 Discovery Profile
7.3.2 Horizo鈥嬧€媙 Discovery Main Business
7.3.3 Horizo鈥嬧€媙 Discovery Gene Editing Products, Services and Solutions
7.3.4 Horizo鈥嬧€媙 Discovery Gene Editing Revenue (US$ Million) & (2019-2024)
7.3.5 Sangamo BioSciences Recent Developments
7.4 Sangamo BioSciences
7.4.1 Sangamo BioSciences Profile
7.4.2 Sangamo BioSciences Main Business
7.4.3 Sangamo BioSciences Gene Editing Products, Services and Solutions
7.4.4 Sangamo BioSciences Gene Editing Revenue (US$ Million) & (2019-2024)
7.4.5 Sangamo BioSciences Recent Developments
7.5 Integrated DNA Technologies
7.5.1 Integrated DNA Technologies Profile
7.5.2 Integrated DNA Technologies Main Business
7.5.3 Integrated DNA Technologies Gene Editing Products, Services and Solutions
7.5.4 Integrated DNA Technologies Gene Editing Revenue (US$ Million) & (2019-2024)
7.5.5 Integrated DNA Technologies Recent Developments
7.6 Lonza
7.6.1 Lonza Profile
7.6.2 Lonza Main Business
7.6.3 Lonza Gene Editing Products, Services and Solutions
7.6.4 Lonza Gene Editing Revenue (US$ Million) & (2019-2024)
7.6.5 Lonza Recent Developments
7.7 New England Biolabs
7.7.1 New England Biolabs Profile
7.7.2 New England Biolabs Main Business
7.7.3 New England Biolabs Gene Editing Products, Services and Solutions
7.7.4 New England Biolabs Gene Editing Revenue (US$ Million) & (2019-2024)
7.7.5 New England Biolabs Recent Developments
7.8 OriGene Technologies
7.8.1 OriGene Technologies Profile
7.8.2 OriGene Technologies Main Business
7.8.3 OriGene Technologies Gene Editing Products, Services and Solutions
7.8.4 OriGene Technologies Gene Editing Revenue (US$ Million) & (2019-2024)
7.8.5 OriGene Technologies Recent Developments
7.9 Transposagen Biopharmaceuticals
7.9.1 Transposagen Biopharmaceuticals Profile
7.9.2 Transposagen Biopharmaceuticals Main Business
7.9.3 Transposagen Biopharmaceuticals Gene Editing Products, Services and Solutions
7.9.4 Transposagen Biopharmaceuticals Gene Editing Revenue (US$ Million) & (2019-2024)
7.9.5 Transposagen Biopharmaceuticals Recent Developments
7.10 Editas Medicine
7.10.1 Editas Medicine Profile
7.10.2 Editas Medicine Main Business
7.10.3 Editas Medicine Gene Editing Products, Services and Solutions
7.10.4 Editas Medicine Gene Editing Revenue (US$ Million) & (2019-2024)
7.10.5 Editas Medicine Recent Developments
7.11 CRISPR Therapeutics
7.11.1 CRISPR Therapeutics Profile
7.11.2 CRISPR Therapeutics Main Business
7.11.3 CRISPR Therapeutics Gene Editing Products, Services and Solutions
7.11.4 CRISPR Therapeutics Gene Editing Revenue (US$ Million) & (2019-2024)
7.11.5 CRISPR Therapeutics Recent Developments
7.12 RGen Solutions
7.12.1 RGen Solutions Profile
7.12.2 RGen Solutions Main Business
7.12.3 RGen Solutions Gene Editing Products, Services and Solutions
7.12.4 RGen Solutions Gene Editing Revenue (US$ Million) & (2019-2024)
7.12.5 RGen Solutions Recent Developments
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Profile
7.13.2 Sigma-Aldrich Main Business
7.13.3 Sigma-Aldrich Gene Editing Products, Services and Solutions
7.13.4 Sigma-Aldrich Gene Editing Revenue (US$ Million) & (2019-2024)
7.13.5 Sigma-Aldrich Recent Developments
7.14 GeneCopoeia
7.14.1 GeneCopoeia Profile
7.14.2 GeneCopoeia Main Business
7.14.3 GeneCopoeia Gene Editing Products, Services and Solutions
7.14.4 GeneCopoeia Gene Editing Revenue (US$ Million) & (2019-2024)
7.14.5 GeneCopoeia Recent Developments
7.15 Genscript Biotech
7.15.1 Genscript Biotech Profile
7.15.2 Genscript Biotech Main Business
7.15.3 Genscript Biotech Gene Editing Products, Services and Solutions
7.15.4 Genscript Biotech Gene Editing Revenue (US$ Million) & (2019-2024)
7.15.5 Genscript Biotech Recent Developments
8 Industry Chain Analysis
8.1 Gene Editing Industrial Chain
8.2 Gene Editing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gene Editing Sales Model
8.5.2 Sales Channel
8.5.3 Gene Editing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Merck
Horizo鈥嬧€媙 Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂